World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

A CLINICAL STUDY OF GUDUCHIBHADRAMUSTADI KASHAYA AND NAVAKA GUGGULU IN THE MANAGEMENT OF MEDOROGA WITH SPECIAL REFERENCE TO DYSLIPIDEMIA

Dr. Bikash Raj Ghimire*, Prof. Sanjay Pokharel and Amrita Ghimire, Dr. Samichha Neupane and Dr. Shwetha kumari Pokharel

ABSTRACT

Dyslipidemia is the serious lifestyle diseases in today?s era of fast and furious life. It has been well described about the consequences of Medo Vikriti and its hazards in our classics. The concept of lipid is correlated with the Dushita Medas. Considering these facts, These study was taken by seeing the present statistics of the incidence and prevalence of Dyslipidemia. Two indigenious drugs Guduchibhadramustadi kashaya and Navaka Guggulu were taken and efficacy and safety profile of both the formulations has been carried out in 3 different groups of 10 patients each. Group I administered with Navaka Guggulu 500mg 2tab BD, Group II with Guduchibhadramustadi kashaya 50ml BD and Group III with both combined formulations were carried out. Result and Discussion reveal that GroupIII administered with both the formulations have shown the good result in relieving both subjective and objective criteria after the course of 1 month.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR